| Name | Title | Contact Details |
|---|
Founded in 2019, Wellvana is a company designed to support independent physicians and help them thrive in their transition to value-based care. With a mission of creating a national footprint of high performing, locally narrow networks, Wellvana aims to deliver high quality and highly efficient healthcare services while contracting on behalf of and migrating physicians towards risk-based reimbursement methodologies. Wellvana provides the resources, experience, and leadership to allow physicians to practice effectively, achieve work life balance, and benefit from risk-based revenue models, while respecting cultural, regional, and individual practice uniqueness.
FORTE is a female founded and led technology company. Launched by Lauren Foundos in 2015, FORTË`s while label streaming platform helps boutique fitness studios, big box gyms and health clubs create premium live and on-demand fitness experiences for members. The FORTË solution is proprietary, turn-key and all inclusive. The company provides hardware and software, and facilitates the entire installation process. By removing complexities associated with production, FORTË`s fully-automated streaming solution allows fitness operators to focus on what they do best - create world-class content and deliver it to members wherever they are.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Fungal Free Nails is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Eurotech Tables/Manufacturing is a Osage Beach, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.